Literature DB >> 17985103

Comparison of uptake characteristics and prognostic value of 201Tl and 18F-FDG in esophageal cancer.

Hyun Woo Chung1, Kyung-Han Lee, Eun Jeong Lee, Su Jin Lee, Young Seok Cho, Joon Young Choi, Young Mog Shim, Kwhanmien Kim, Byung-Tae Kim.   

Abstract

BACKGROUND: Patients with esophageal cancer often undergo (201)Tl myocardial imaging for preoperative risk evaluation, thereby providing an excellent opportunity to assess tumor handling of (201)Tl. We thus compared the characteristics of (201)Tl and (18)F-FDG uptake by esophageal cancer and further investigated their prognostic values.
METHODS: The study included 100 newly diagnosed esophageal cancer patients who underwent preoperative (201)Tl SPECT and (18)F-FDG PET exams. Tumor to mediastinal uptake (T/M) ratio and retention index (RI) of (201)Tl, tumor (18)F-FDG pSUV, tumor size, location, and stage were assessed. Survival analysis was performed for disease-free survival using the Kaplan-Meier method. Cox proportional hazard models were used to determine independent risk factors.
RESULTS: (201)Tl SPECT and (18)F-FDG PET visualized the primary tumor in 85/100 (85.0%) and 91/100 (91.0%) patients, respectively (p = 0.03). There were close correlations between early and delayed (201)Tl T/M ratios (r = 0.83, p < 0.0001) and between T/M ratios and (18)F-FDG pSUV (r = 0.56 and 0.57, respectively, both p < 0.0001). Both T/M ratios and (18)F-FDG pSUV correlated significantly with tumor stage (rho = 0.45, 0.40, and 0.59, respectively, all p < 0.0001). Survival analysis revealed tumor size, (201)Tl negative tumors, (18)F-FDG negative tumors, delayed (201)Tl T/M ratio, RI, stage, and (18)F-FDG pSUV to be significant univariate predictors for disease-free survival. Multivariate survival analysis showed stage (p = 0.02) to be a significant independent prognostic predictor.
CONCLUSIONS: In patients with esophageal cancer, assessment of tumor (201)Tl uptake, as with (18)F-FDG, may provide potentially useful information regarding tumor characteristics.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17985103     DOI: 10.1007/s00268-007-9276-z

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  24 in total

1.  Comparison of barium swallow, CT and thallium-201 SPECT in evaluating responses of patients with esophageal squamous cell carcinoma to preoperative chemoradiotherapy.

Authors:  Tadaki Nakahara; Takashi Togawa; Matsuo Nagata; Kazunori Kikuchi; Kazuo Hatano; Nobuharu Yui; Atsushi Kubo
Journal:  Ann Nucl Med       Date:  2003-10       Impact factor: 2.668

2.  201Tl scintigraphy in the evaluation of palpable and nonpalpable breast lesions: correlation with mammography and ultrasonography.

Authors:  G Vural; T Atasever; A Ozdemir; I Oznur; N I Karabacak; N Gökçora; S Işik; M Unlü
Journal:  Nuklearmedizin       Date:  1997-12       Impact factor: 1.379

3.  Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma.

Authors:  P Flamen; A Lerut; E Van Cutsem; W De Wever; M Peeters; S Stroobants; P Dupont; G Bormans; M Hiele; P De Leyn; D Van Raemdonck; W Coosemans; N Ectors; K Haustermans; L Mortelmans
Journal:  J Clin Oncol       Date:  2000-09-15       Impact factor: 44.544

4.  Initial application of respiratory-gated 201Tl SPECT in pulmonary malignant tumours.

Authors:  Yasuhiko Kawakami; Kazuyoshi Suga; Tomio Yamashita; Hideyuki Iwanaga; Mohammed Zaki; Naofumi Matsunaga
Journal:  Nucl Med Commun       Date:  2005-04       Impact factor: 1.690

Review 5.  Position of positron emission tomography and other imaging diagnostic modalities in esophageal cancer.

Authors:  P Flamen; T Lerut; K Haustermans; E Van Cutsem; L Mortelmans
Journal:  Q J Nucl Med Mol Imaging       Date:  2004-06       Impact factor: 2.346

6.  Risk stratification and long-term results after surgical treatment of carcinomas of the thoracic esophagus and cardia. A 25-year retrospective study.

Authors:  O Lund; H H Kimose; M T Aagaard; J M Hasenkam; M Erlandsen
Journal:  J Thorac Cardiovasc Surg       Date:  1990-02       Impact factor: 5.209

7.  Risk analysis in resection of squamous cell carcinoma of the esophagus.

Authors:  S Y Law; M Fok; J Wong
Journal:  World J Surg       Date:  1994 May-Jun       Impact factor: 3.352

Review 8.  Factors affecting postoperative course and survival after en bloc resection for esophageal carcinoma.

Authors:  Christophe Mariette; Guillaume Taillier; Isabelle Van Seuningen; Jean-Pierre Triboulet
Journal:  Ann Thorac Surg       Date:  2004-10       Impact factor: 4.330

9.  Preoperative risk analysis and postoperative mortality of oesophagectomy for resectable oesophageal cancer.

Authors:  H Bartels; H J Stein; J R Siewert
Journal:  Br J Surg       Date:  1998-06       Impact factor: 6.939

10.  Treatment outcomes of resected esophageal cancer.

Authors:  Wayne Hofstetter; Stephen G Swisher; Arlene M Correa; Kenneth Hess; Joe B Putnam; Jaffer A Ajani; Marcelo Dolormente; Rhodette Francisco; Ritsuko R Komaki; Axbal Lara; Faye Martin; David C Rice; Arcenio J Sarabia; W Roy Smythe; Ara A Vaporciyan; Garrett L Walsh; Jack A Roth
Journal:  Ann Surg       Date:  2002-09       Impact factor: 12.969

View more
  2 in total

1.  Accuracy of PET-CT in predicting survival in patients with esophageal cancer.

Authors:  Claire Brown; Ben Howes; Glyn G Jamieson; Dylan Bartholomeusz; Urs Zingg; Thomas R Sullivan; Sarah K Thompson
Journal:  World J Surg       Date:  2012-05       Impact factor: 3.352

2.  Clinical significance of primary lesion FDG uptake for choice between oesophagectomy and endoscopic submucosal dissection for resectable oesophageal squamous cell carcinomas.

Authors:  Masatoyo Nakajo; Masayuki Nakajo; Atsushi Tani; Yoriko Kajiya; Shunji Shimaoka; Akio Matsuda; Tatsuyuki Nioh; Tohru Nihara; Toyokuni Suenaga; Sadao Tanaka; Hiroshi Shirahama; Michiyo Higashi; Chihaya Koriyama
Journal:  Eur Radiol       Date:  2011-07-13       Impact factor: 5.315

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.